Major moves in pharma and biotech partnering are reshaping the landscape. For ADC companies, the challenge lies in standing out, validating their offerings, and securing clinical-ready assets amidst this whirlwind of activity.

制药和生物技术合作的重大举措正在重塑这一格局。对于ADC公司来说，挑战在于脱颖而出，验证他们的产品，并在这种活动的旋风中确保临床就绪的资产。

How does one differentiate and obtain assets poised for clinical success in the next wave of deals?

如何在下一波交易中区分并获得准备取得临床成功的资产？

Enter the ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit.

参加ADC和放射性药物制药和生物技术合作峰会。

Cuts through the noise of partnership events to gather a targeted critical mass of 100+ ADC companies

打破伙伴关系活动的喧嚣，聚集100多家ADC公司的目标临界数量

Provides a platform for networking and fast-tracking the search and evaluation of earlier development assets

提供一个平台，用于联网和快速跟踪早期开发资产的搜索和评估

Empowers participants to navigate the complex partnering landscape with confidence by significantly improving the alignment, efficiency, and yield of conversations

通过显著提高对话的一致性、效率和收益率，使参与者能够自信地驾驭复杂的合作环境

VIEW THE FULL EVENT GUIDE

查看完整的活动指南

If you have any questions, please get in touch with the team here: info@hansonwade.com

如果您有任何问题，请在此处与团队联系：info@hansonwade.com

Understand how to transition your potency assay from early to late-stage

了解如何将效力测定从早期过渡到晚期

Explore how NGS methods can better inform your genome titers

探索NGS方法如何更好地告知您的基因组滴度

Accurately measure partials in your samples

准确测量样本中的部分

Produce contaminant-free and high yield vector batches at scale

大规模生产无污染且高产的载体批次

Secure your place here or get in touch with the team – info@hansonwade.com

确保您的位置安全或与团队取得联系——info@hansonwade.com